Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Betsy Davis

Betsy Davis

Senior Strategic Marketing Manager

Connect with Betsy Davis on LinkedIn
Follow Betsy Davis on Twitter
Website:

About the author: Betsy’s entire marketing career has exclusively focused on the STEM market, with a distinct emphasis on Pharma. During her tenure with Elsevier’s Corporate R&D group, she has managed market segmentation for the pharma and life sciences industry, and launched and manages The Hive, a partnership with a select group of biotech and pharmaceutical start-ups focused on early stage innovation in drug discovery and development. The program promotes collaboration and inspiration across the Pharma & Life Sciences industry. Prior to launching her marketing career, Betsy worked as a management consultant focused on strategy implementation. She holds an MBA from the University of Michigan’s Ross School of Business and a BA from Barnard College of Columbia University.

Posts by Betsy Davis

How will Brexit effect Multinationals and Pharmaceutical Companies?

Posted on June 30th, 2016 in Pharma R&D

One of the most stunning upsets to happen in global politics in decades transpired on June 23 when the people of the United Kingdom voted to leave the European Union. (more…)

What Does the 2016 US Election Mean For Pharma?

Posted on June 28th, 2016 in Pharma R&D

With summer, the 2016 U.S. Presidential Election is now truly heating up as we have presumptive nominees from the two major political parties. While we are hearing a lot about issues like national security and immigration from Republican nominee Donald Trump and Democratic nominee Hillary Clinton, those working in the pharmaceutical industry may be wondering how their sector will be affected by the eventual winner. (more…)

A Holistic Cure for the Pharmaceutical Industry’s Ailments

Posted on June 17th, 2016 in Pharma R&D

Since the turn of the century, the pharmaceutical industry has seen dramatic changes, including dwindling drug pipelines, looming patent expirations and rising costs. (more…)

Biotech by the Bay

Posted on June 13th, 2016 in Pharma R&D

The Bay Area was a hotbed of biotech conversation and activity this past week, as the BIO International Convention hit San Francisco from June 6-9. The convention is self-dubbed as “The Global Event for Biotechnology,” and that is not hyperbole. (more…)

  1. 1
  2. 15
  3. 16
  4. 17
  5. 18
  6. 19